Chilblain-like acral lesions during the COVID-19 pandemic (“COVID toes”): Histologic, immunofluorescence, and immunohistochemical study of 17 cases - 19/08/20
, Cécile Lesort, MD a, Marie Danset, MD a, Denis Jullien, MD, PhD a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
During the coronavirus disease 2019 pandemic, several acral chilblain-like lesions were observed in young patients with suspected, but mostly unconfirmed, infection with severe acute respiratory syndrome coronavirus 2. The histopathologic aspect of these lesions is as yet poorly known.
Objective |
To investigate the pathologic features of chilblain-like lesions.
Methods |
Biopsies were obtained from 17 cases of chilblain-like lesions during the coronavirus disease 2019 pandemic in France and were studied by routine histologic examination, immunohistochemistry, and direct immunofluorescence. The patients had suspected but unconfirmed infection with severe acute respiratory syndrome coronavirus 2 (negative nasopharyngeal polymerase chain reaction and serologic test results).
Results |
Chilblain-like lesions showed many features in common with those reported in idiopathic and autoimmune-related chilblains, including epidermal necrotic keratinocytes, dermal edema, perivascular and perieccrine sweat gland lymphocytic (predominantly CD3/CD4+) inflammation, and frequent vascular changes (endothelialitis, microthromboses, fibrin deposition, and immunoreactant deposits on vessels).
Conclusions |
Chilblain-like lesions show histopathologic features similar to those of idiopathic and autoimmune-related chilblains, with a high rate of vascular changes and direct immunofluorescence positivity. The role of severe acute respiratory syndrome coronavirus 2 in the development of these puzzling lesions remains to be elucidated.
Le texte complet de cet article est disponible en PDF.Key words : chilblains, COVID-19, dermatopathology, direct immunofluorescence, eosinophils, immunohistochemistry, SARS-CoV-2
Plan
| Drs Kanitakis and Lesort contributed equally to the article. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
Vol 83 - N° 3
P. 870-875 - septembre 2020 Retour au numéro
Article précédent
- Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain
- Michael R. Sargen, Donato Calista, David E. Elder, Daniela Massi, Emily Y. Chu, Míriam Potrony, Ruth M. Pfeiffer, Cristina Carrera, Paula Aguilera, Llucia Alos, Susana Puig, Rosalie Elenitsas, Xiaohong R. Yang, Margaret A. Tucker, Maria Teresa Landi, Alisa M. Goldstein
- Treatments of actinic cheilitis: A systematic review of the literature
- Michela Lai, Riccardo Pampena, Luigi Cornacchia, Giovanni Pellacani, Ketty Peris, Caterina Longo
Bienvenue sur EM-consulte, la référence des professionnels de santé.